These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4020951)

  • 21. Enteral absorption and bioavailability in children in relation to age.
    Heimann G
    Eur J Clin Pharmacol; 1980 Jul; 18(1):43-50. PubMed ID: 7398747
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of phenobarbital on digitoxin and digoxin elimination in the dog.
    Breznock EM
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):371-3. PubMed ID: 1124874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, bioavailability, and hemodynamic effects of trazodone after intravenous and oral administration of a single dose to dogs.
    Jay AR; Krotscheck U; Parsley E; Benson L; Kravitz A; Mulligan A; Silva J; Mohammed H; Schwark WS
    Am J Vet Res; 2013 Nov; 74(11):1450-6. PubMed ID: 24168312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosage form design for improvement of bioavailability of levodopa II: bioavailability of marketed levodopa preparations in dogs and parkinsonian patients.
    Sasahara K; Nitanai T; Habara T; Morioka T; Nakajima E
    J Pharm Sci; 1980 May; 69(3):261-5. PubMed ID: 7381698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma and cerebrospinal fluid concentrations of phenobarbital in infants given single doses.
    Jalling B
    Dev Med Child Neurol; 1974 Dec; 16(6):781-93. PubMed ID: 4442659
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of route of administration on physiological availability of levodopa in dogs.
    Cotler S; Holazo A; Boxenbaum HG; Kaplan SA
    J Pharm Sci; 1976 Jun; 65(6):822-7. PubMed ID: 932965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs.
    Abbo LA; Ko JC; Maxwell LK; Galinsky RE; Moody DE; Johnson BM; Fang WB
    Vet Ther; 2008; 9(2):83-93. PubMed ID: 18597246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of phenobarbitone in protein energy malnutrition.
    Syed GB; Sharma DB; Raina RK
    Dev Pharmacol Ther; 1986; 9(5):317-22. PubMed ID: 3096674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of absorption and elimination of pralidoxime chloride in dogs.
    Lemanowicz EF; Sugita ET; Niebergall PJ; Schnaare RL
    J Pharm Sci; 1979 Feb; 68(2):141-5. PubMed ID: 423079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors involved in the choice of routes of administration of antimicrobial drugs.
    Baggot JD
    J Am Vet Med Assoc; 1984 Nov; 185(10):1076-82. PubMed ID: 6392233
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics and bioavailability of intravenous, oral, and rectal nitrazepam in humans.
    Jochemsen R; Hogendoorn JJ; Dingemanse J; Hermans J; Boeijinga JK; Breimer DD
    J Pharmacokinet Biopharm; 1982 Jun; 10(3):231-45. PubMed ID: 7175697
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral absorption and bioavailability of fenbendazole in the dog and the effect of concurrent ingestion of food.
    McKellar QA; Galbraith EA; Baxter P
    J Vet Pharmacol Ther; 1993 Jun; 16(2):189-98. PubMed ID: 8345569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of phenobarbital in the cat following intravenous and oral administration.
    Cochrane SM; Black WD; Parent JM; Allen DG; Lumsden JH
    Can J Vet Res; 1990 Jan; 54(1):132-8. PubMed ID: 2306662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative kinetics of phenobarbital after administration of the acid and the propylhexedrine salt (barbexaclone).
    Perucca E; Grimaldi R; Ruberto G; Gelmi C; Trimarchi F; Crema A
    Eur J Clin Pharmacol; 1986; 29(6):729-30. PubMed ID: 3709618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral bioavailability of quercetin from different quercetin glycosides in dogs.
    Reinboth M; Wolffram S; Abraham G; Ungemach FR; Cermak R
    Br J Nutr; 2010 Jul; 104(2):198-203. PubMed ID: 20230651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ingesta on systemic availability of phenobarbitone in dogs.
    Watson AD; Church DB; Emslie DR; Tsoukalas G; Griffin DL; Baggot JD
    Aust Vet J; 1996 Mar; 73(3):108-9. PubMed ID: 8660210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.